Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Net Margin (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Net Margin for 3 consecutive years, with 1673.5% as the latest value for Q1 2022.

  • Quarterly Net Margin fell 163134.0% to 1673.5% in Q1 2022 from the year-ago period, while the trailing twelve-month figure was 4195.0% through Dec 2022, down 392264.0% year-over-year, with the annual reading at 4130.1% for FY2022, 385774.0% down from the prior year.
  • Net Margin for Q1 2022 was 1673.5% at SELLAS Life Sciences, down from 242.79% in the prior quarter.
  • The five-year high for Net Margin was 42.16% in Q1 2021, with the low at 1673.5% in Q1 2022.
  • Average Net Margin over 3 years is 538.51%, with a median of 219.18% recorded in 2020.
  • Peak annual rise in Net Margin hit -163134bps in 2022, while the deepest fall reached -163134bps in 2022.
  • Over 3 years, Net Margin stood at 195.58% in 2020, then decreased by -24bps to 242.79% in 2021, then crashed by -589bps to 1673.5% in 2022.
  • According to Business Quant data, Net Margin over the past three periods came in at 1673.5%, 242.79%, and 42.16% for Q1 2022, Q2 2021, and Q1 2021 respectively.